Studies have suggested that TNF-α blockers can stimulate the formation of anti-tumor necrosis factor or tumor necrosis factor-containing immune complexes in small vessels and subsequently activating the complement pathway to induce vasculitis (132). This evidence concerns the gene TNF and vasculitis.